Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q1 EPS of ($0.55), $0.09 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.